瘤获得的体质突变会影响形状,从而消除ABCG2介导的耐药性
Tomoka Gose1, Ali Rasouli2, Sepehr Dehghani-Ghahnaviyeh2
1Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA.
在ABCG2输送器 (Q393K) 中的瘤突变通过将其锁定在非功能状态中来防止药物耐药性. 这一发现为传送机制和药物相互作用提供了洞察力.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 结合ATP的磁带载体ABCG2影响药物的吸收和分布.
- ABCG2调解细胞对各种化疗剂的耐药性.
- 在ABCG2保存的氨基酸中的体质突变可以揭示运输机制.
研究的目的:
- 为了研究瘤衍生的体质突变 (Q393K) 在ABCG2.2保存的氨基酸残留中的功能影响.
- 阐明Q393K突变影响ABCG2转运器功能和耐药性的分子机制.
主要方法:
- 在ABCG2.2.中识别瘤衍生的体质突变 (Q393K).
- 评估突变者的本地化,基质和核酸相互作用.
- 使用形状敏感的抗体来评估输送器形状.
- 采用基于冷电磁结构的结构建模和分子动力学模拟.
主要成果:
- 在ABCG2中的Q393K突变似乎无法赋予耐药性,尽管适当的局部化和基质/核酸相互作用.
- 一个形状敏感的抗体表明突变者"被锁定"在一个非功能性形状中.
- 结构建模和模拟显示Q393K突变与E446形成盐桥,稳定了面向内部的形状.
- 这种稳定损害了传送器的灵活性,并破坏了基板结合和运输之间的通信.
结论:
- Q393K突变破坏了ABCG2的功能,稳定了向内面的形状,防止了运输所需的形状灵活性.
- 这项研究提供了关于特定突变如何损害载体活动的分子洞察力,从而影响药物耐药性.
- 了解这些机制可以为癌症治疗和药物开发策略提供信息.
更多相关视频
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
相关概念视频
Treatment Resistant Cancers
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Abnormal Proliferation
